Sanjay Kulkarni, MD, FACS, MHCM

Associate Professor of Surgery (Transplant) and of Medicine (Nephrology); Medical Director, Center for Living Organ Donors; Scientific Director, Yale Transplant Research Unit; Surgical Director, Kidney Transplant Program; UNOS Primary Living Donor Surgeon

Clinical Interests

  • Behavioral Disciplines and Activities
  • Environment and Public Health
  • Surgical Procedures, Operative
  • Therapeutics

Patient Care

Accepts new patients? Yes
Patient Type: Adult; Adolescent; Child
Referrals: From patients or physicians

Patient Care Organizations

Surgery: Transplant & Immunology Surgery

Internal Medicine: Liver Center | Nephrology

Transplantation Center

Yale Cancer Center

Yale Medicine

Office of Cooperative Research

Board Certifications

  • Surgery, General AB of Surgery (2003)

Clinical Trials

Conditions Study Title
Diseases of the Digestive System - Liver 13C-Methacetin Breath Test for the Prediction of Outcome in in ALI or ALF (ALFSG-MBT)
Diseases of the Kidney & Urinary Tract, Men's Health, Women's Health Effects of Inhibiting Early Inflammation in Kidney Transplant Patients

Edit this profile

Contact Info

Sanjay Kulkarni, MD, FACS, MHCM
Patient Care Locations
Yale-New Haven Transplantation CenterYale Physicians Building
800 Howard Avenue, Ste 3rd floor

New Haven, CT 06519
View on map...
Yale Transplant & ImmunologyFarnam Memorial Building
310 Cedar Street

New Haven, CT 06510
View on map...
Mailing Address
Transplant & ImmunologyPO Box 208062
New Haven, CT 06520-8062

Curriculum Vitae

Eculizumab for Chronic Antibody-Mediated Injury in Kidney Transplant Recipients

Graph shows all clinical trial patients randomized to the treatment arm. Treatment patients received 6 months of eculizumab treatment followed by 6 months of observation.